Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursofalk 500 mg Tablets vs 250 mg Capsules in PBC
NCT01510860Phase 4Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Nov 2008
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in primary biliary cholangitis (PBC), sponsored by Dr. Falk Pharma GmbH. Started Nov 2008; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT01510860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510860.